CD59 and esophageal squamous cell carcinoma: To further evaluate the impact of CD59 on radioresistance in ESCC, we first generated CD59 knockout cell lines, Eca109-CD59-KO and KYSE510-CD59-KO, using a CRISPR-Cas9 strategy, the efficacy of which was verified by western blot (Fig. 2a).